Susquehanna International Group, LLP Y M Abs Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$6.57 - $18.69 $176,076 - $500,892	26,800 New	26,800 $435,000
Q4 2022 Feb 14, 2023	SELL	$3.0 - $15.17 $140,100 - $708,439	-46,700 Reduced 80.94%	11,000 $53,000
Q3 2022 Nov 14, 2022	SELL	$13.96 - $19.67 $29,316 - $41,307	-2,100 Reduced 3.51%	57,700 $832,000
Q2 2022 Aug 15, 2022	BUY	$8.22 - $15.13 $234,270 - $431,205	28,500 Added 91.05%	59,800 $905,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $205,015 - $545,246	31,300 New	31,300 $372,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.